Pharmacokinetics of a Fixed-Dose Combination Product of Amlodipine, Losartan, Ezetimibe, and Rosuvastatin and Its Comparison with Co-administration of Four Individual Components in Healthy Participants

MLA

Jin-Woo Park, et al. “Pharmacokinetics of a Fixed-Dose Combination Product of Amlodipine, Losartan, Ezetimibe, and Rosuvastatin and Its Comparison with Co-Administration of Four Individual Components in Healthy Participants.” Drugs in R&D, vol. 24, no. 2, May 2024, pp. 179–86. EBSCOhost, https://doi.org/10.1007/s40268-024-00460-y.

APA

Jin-Woo Park, Hyewon Chung, Jong-Min Kim, Na Young Kim, Sung Hee Hong, Kyoung-Ah Kim, & Ji-Young Park. (2024). Pharmacokinetics of a Fixed-Dose Combination Product of Amlodipine, Losartan, Ezetimibe, and Rosuvastatin and Its Comparison with Co-administration of Four Individual Components in Healthy Participants. Drugs in R&D, 24(2), 179–186. https://doi.org/10.1007/s40268-024-00460-y

Chicago

Jin-Woo Park, Hyewon Chung, Jong-Min Kim, Na Young Kim, Sung Hee Hong, Kyoung-Ah Kim, and Ji-Young Park. 2024. “Pharmacokinetics of a Fixed-Dose Combination Product of Amlodipine, Losartan, Ezetimibe, and Rosuvastatin and Its Comparison with Co-Administration of Four Individual Components in Healthy Participants.” Drugs in R&D 24 (2): 179–86. doi:10.1007/s40268-024-00460-y.